Denne side blev automatisk oversat, og nøjagtigheden af ​​oversættelsen er ikke garanteret. Der henvises til engelsk version for en kildetekst.

Physiotherapy for Infants With Bronchiolities

24. september 2021 opdateret af: Lund University

Physiotherapy Including Frequent Changes of Body Position and Stimulation to Physical Activity for Infants With Bronchiolitis and Other Acute Respiratory Infections - a Randomized Controlled Trial

Children who are in a hospital with respiratory distress often have difficulty breathing, have thick mucus, and may find it hard to eat normally. Sometimes physical therapy is used to treat these children, but it is not entirely known which methods help the children's condition. The aim of this study is to evaluate the most common physiotherapy treatment method that is currently in use in Sweden for infants who are hospitalized with a lower respiratory infection.

Studieoversigt

Detaljeret beskrivelse

All children under 2 years of age who are admitted to the hospital for a respiratory infection and who have previously been essentially healthy are asked to participate. The infants will be randomized to 3 groups, 1 control group and 2 intervention groups. The infants in the control group will receive the standard care at the clinic. In one intervention group the parents will receive instructions how to vary their child body position regularly, and in the other intervention group the child will receive physiotherapy regularly and the parents will carry out some treatment. Further actions in the form of inhalations or stimulation of deep breathing, will be used when needed. The children will be observed following a structured observational protocol regularly throughout the hospital stay.

Undersøgelsestype

Interventionel

Tilmelding (Forventet)

120

Fase

  • Ikke anvendelig

Kontakter og lokationer

Dette afsnit indeholder kontaktoplysninger for dem, der udfører undersøgelsen, og oplysninger om, hvor denne undersøgelse udføres.

Studiekontakt

Undersøgelse Kontakt Backup

Studiesteder

Deltagelseskriterier

Forskere leder efter personer, der passer til en bestemt beskrivelse, kaldet berettigelseskriterier. Nogle eksempler på disse kriterier er en persons generelle helbredstilstand eller tidligere behandlinger.

Berettigelseskriterier

Aldre berettiget til at studere

1 sekund til 2 år (Barn)

Tager imod sunde frivillige

Ingen

Køn, der er berettiget til at studere

Alle

Beskrivelse

Inclusion Criteria:

  • Infants hospitalized because of respiratory infections such as bronchiolitis, pneumonia or other airway obstructions.
  • Age 0-24 months
  • Born in gestation week 35 or later.
  • Guardians understand written Swedish, English, Arabic or Persian

Exclusion Criteria:

  • Previous cardiac or respiratory disease
  • hospitalized more than 24 hours on this occasion

Studieplan

Dette afsnit indeholder detaljer om studieplanen, herunder hvordan undersøgelsen er designet, og hvad undersøgelsen måler.

Hvordan er undersøgelsen tilrettelagt?

Design detaljer

  • Primært formål: Behandling
  • Tildeling: Randomiseret
  • Interventionel model: Parallel tildeling
  • Maskning: Enkelt

Våben og indgreb

Deltagergruppe / Arm
Intervention / Behandling
Ingen indgriben: control group
The infants will receive the standard care at the ward.
Eksperimentel: Non-individualized
The parents will be guided manually by the nursing staff and receive written information about how to change body positions of their child regularly throughout the hospital stay.
Comparing two experimental interventions with standard care
Eksperimentel: Individualized
The infant will receive frequent changes of body positions, stimulation to physical activity, and stimulation to deep breathing while bouncing on a large ball in the arms of an adult. Additional light chest compressions and inhalations may be given. A physiotherapist will perform the intervention at least once daily, and the parents will be manually guided and receive written information about how to change body positions of their child regularly in a similar way throughout the hospital stay.
Comparing two experimental interventions with standard care

Hvad måler undersøgelsen?

Primære resultatmål

Resultatmål
Foranstaltningsbeskrivelse
Tidsramme
Time to improvement
Tidsramme: Baseline, after 20 minutes, and every third hour up to discharge from hospital, no more than two weeks
First improvement regarding any of the following: Wang respiratory score, use of supplemented oxygen, use of supplemented high air flow, use of tube feeding, hospital stay
Baseline, after 20 minutes, and every third hour up to discharge from hospital, no more than two weeks

Sekundære resultatmål

Resultatmål
Foranstaltningsbeskrivelse
Tidsramme
oxygen saturation
Tidsramme: Baseline and second assessment, directly following the first intervention (or interval) after 20 minutes
Change in percutanous oxygen saturation measured by probe on the foot
Baseline and second assessment, directly following the first intervention (or interval) after 20 minutes
respiratory rate
Tidsramme: Baseline and second assessment, directly following the first intervention (or interval) after 20 minutes
Change in manually counted RR during one minute
Baseline and second assessment, directly following the first intervention (or interval) after 20 minutes
Heart rate
Tidsramme: Baseline and second assessment, directly following the first intervention (or interval) after 20 minutes
Change in pulse oximeter
Baseline and second assessment, directly following the first intervention (or interval) after 20 minutes
General condition, parents' assessment
Tidsramme: Baseline and every third hour up to discharge from hospital, no more than two weeks
Time to the first reduction in Numeric Rating Scale 0-10, (0 the best, 10 the worst)
Baseline and every third hour up to discharge from hospital, no more than two weeks
Lung complications
Tidsramme: At discharge from the ward, no more than two weeks
Referral to an intensive care unit
At discharge from the ward, no more than two weeks

Samarbejdspartnere og efterforskere

Det er her, du vil finde personer og organisationer, der er involveret i denne undersøgelse.

Sponsor

Publikationer og nyttige links

Den person, der er ansvarlig for at indtaste oplysninger om undersøgelsen, leverer frivilligt disse publikationer. Disse kan handle om alt relateret til undersøgelsen.

Datoer for undersøgelser

Disse datoer sporer fremskridtene for indsendelser af undersøgelsesrekord og resumeresultater til ClinicalTrials.gov. Studieregistreringer og rapporterede resultater gennemgås af National Library of Medicine (NLM) for at sikre, at de opfylder specifikke kvalitetskontrolstandarder, før de offentliggøres på den offentlige hjemmeside.

Studer store datoer

Studiestart (Faktiske)

23. januar 2018

Primær færdiggørelse (Forventet)

31. maj 2022

Studieafslutning (Forventet)

31. december 2022

Datoer for studieregistrering

Først indsendt

13. oktober 2017

Først indsendt, der opfyldte QC-kriterier

29. juni 2018

Først opslået (Faktiske)

2. juli 2018

Opdateringer af undersøgelsesjournaler

Sidste opdatering sendt (Faktiske)

30. september 2021

Sidste opdatering indsendt, der opfyldte kvalitetskontrolkriterier

24. september 2021

Sidst verificeret

1. september 2021

Mere information

Begreber relateret til denne undersøgelse

Andre undersøgelses-id-numre

  • 2017/190

Plan for individuelle deltagerdata (IPD)

Planlægger du at dele individuelle deltagerdata (IPD)?

Ingen

Lægemiddel- og udstyrsoplysninger, undersøgelsesdokumenter

Studerer et amerikansk FDA-reguleret lægemiddelprodukt

Ingen

Studerer et amerikansk FDA-reguleret enhedsprodukt

Ingen

produkt fremstillet i og eksporteret fra U.S.A.

Ingen

Disse oplysninger blev hentet direkte fra webstedet clinicaltrials.gov uden ændringer. Hvis du har nogen anmodninger om at ændre, fjerne eller opdatere dine undersøgelsesoplysninger, bedes du kontakte register@clinicaltrials.gov. Så snart en ændring er implementeret på clinicaltrials.gov, vil denne også blive opdateret automatisk på vores hjemmeside .

Abonner